United Drug purchases rival

UNITED Drug will hit its target of taking 40% of the British contract sales outsourcing (CSO) drug market with the purchase yesterday of NASDAQ-quoted Ventiv Health Inc in a €7.5m cash deal.

Ventiv Health, which is listed on the NASDAQ Stock Market has over 30 years experience serving the pharmaceutical and life science industries and has an extensive range of clients across the US and Europe.

The acquisition has been completed through Ashfield Healthcare Ltd, United Drug’s contract sales outsourcing division with operations in Britain and Ireland.